{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T06:10:58Z","timestamp":1770963058342,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.thromres.2014.12.026","type":"journal-article","created":{"date-parts":[[2015,1,2]],"date-time":"2015-01-02T16:15:53Z","timestamp":1420215353000},"page":"485-491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["An international, multicenter, prospective study of a prothrombin complex concentrate, Prothromplex Total\u00ae, in anticoagulant reversal"],"prefix":"10.1016","volume":"135","author":[{"given":"\u00c1ron","family":"Altorjay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9va","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zolt\u00e1n","family":"Boda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludwig","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leock Y.","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Engl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4919-7786","authenticated-orcid":false,"given":"Clair L.","family":"Firth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik R.","family":"Ahlstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Gelmont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Pabinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2014.12.026_bb0005","doi-asserted-by":"crossref","first-page":"e44S","DOI":"10.1378\/chest.11-2292","article-title":"Oral anticoagulant therapy: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Ageno","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2014.12.026_bb0010","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2014.12.026_bb0015","doi-asserted-by":"crossref","first-page":"893","DOI":"10.7326\/0003-4819-139-11-200312020-00007","article-title":"Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous Thromboembolism A Meta-Analysis","volume":"139","author":"Linkins","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thromres.2014.12.026_bb0020","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1023\/A:1008897300003","article-title":"The Prothrombinase Complex: Assembly and Function","volume":"4","author":"Spencer","year":"1997","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.thromres.2014.12.026_bb0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/bjh.12107","article-title":"Guideline on the management of bleeding in patients on antithrombotic agents","volume":"160","author":"Makris","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2014.12.026_bb0030","doi-asserted-by":"crossref","first-page":"198","DOI":"10.5694\/mja12.10614","article-title":"An update of consensus guidelines for warfarin reversal","volume":"198","author":"Tran","year":"2013","journal-title":"Med J Aust"},{"key":"10.1016\/j.thromres.2014.12.026_bb0035","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1046\/j.1365-2141.2001.03214.x","article-title":"Beriplex P\/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding","volume":"115","author":"Evans","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2014.12.026_bb0040","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1055\/s-0038-1655992","article-title":"Emergency oral anticoagulant reversal: The relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy","volume":"77","author":"Makris","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.12.026_bb0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ajh.21046","article-title":"Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature","volume":"83","author":"Leissinger","year":"2008","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.thromres.2014.12.026_bb0050","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.113.002283","article-title":"Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study","volume":"128","author":"Sarode","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2014.12.026_bb0055","doi-asserted-by":"crossref","first-page":"204S","DOI":"10.1378\/chest.126.3_suppl.204S","article-title":"The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Ansell","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2014.12.026_bb0060","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2141.2005.05856.x","article-title":"Guidelines on oral anticoagulation (warfarin): third edition-2005 update","volume":"132","author":"Baglin","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2014.12.026_bb0065","doi-asserted-by":"crossref","first-page":"492","DOI":"10.5694\/j.1326-5377.2004.tb06407.x","article-title":"Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis","volume":"181","author":"Baker","year":"2004","journal-title":"Med J Aust"},{"key":"10.1016\/j.thromres.2014.12.026_bb0070","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1161\/01.CIR.0000063575.17904.4E","article-title":"American Heart Association\/American College of Cardiology Foundation guide to warfarin therapy","volume":"107","author":"Hirsh","year":"2003","journal-title":"Circulation"},{"issue":"Suppl. 2","key":"10.1016\/j.thromres.2014.12.026_bb0075","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0049-3848(08)70004-5","article-title":"Warfarin-induced bleeding complications - clinical presentation and therapeutic options","volume":"122","author":"Wiedermann","year":"2008","journal-title":"Thromb Res"},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2014.12.026_bb0080","first-page":"S97","article-title":"Prothrombin complex concentrate versus fresh frozen plasma in patients on oral anticoagulant therapy undergoing cardiac surgery: a randomized study","volume":"10","author":"Demeyere","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.thromres.2014.12.026_bb0085","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.thromres.2004.04.004","article-title":"Efficacy and safety of a prothrombin complex concentrate (Octaplex) for rapid reversal of oral anticoagulation","volume":"113","author":"Lubetsky","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2014.12.026_bb0090","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/MBC.0b013e3282010d7a","article-title":"Successful emergency reversal of phenprocoumon anticoagulation with prothrombin complex concentrate: a prospective clinical study","volume":"18","author":"Lorenz","year":"2007","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.thromres.2014.12.026_bb0095","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1538-7836.2008.02904.x","article-title":"Prothrombin complex concentrate (Beriplex\u00ae P\/N) for emergency anticoagulation reversal: a prospective multinational clinical trial","volume":"6","author":"Pabinger","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2014.12.026_bb0100","first-page":"3","article-title":"Prospective evaluation of a regional protocol for rapid warfarin reversal in major haemorrhage","volume":"121","author":"Sharples","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2014.12.026_bb0105","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.thromres.2005.08.005","article-title":"Individual dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: an open, prospective randomized controlled trial","volume":"118","author":"van Aart","year":"2006","journal-title":"Thromb Res"},{"issue":"6027","key":"10.1016\/j.thromres.2014.12.026_bb0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.2.6027.83","article-title":"Comparison of prothrombin complex concentrate and vitamin K1 in oral anticoagulant reversal","volume":"2","author":"Taberner","year":"1976","journal-title":"Br Med J"},{"issue":"1","key":"10.1016\/j.thromres.2014.12.026_bb0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0049-3848(02)00402-4","article-title":"Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication","volume":"108","author":"Yasaka","year":"2002","journal-title":"Thromb Res"},{"issue":"13","key":"10.1016\/j.thromres.2014.12.026_bb0120","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1182\/blood-2008-06-165845","article-title":"D-dimer antigen: current concepts and future prospects","volume":"113","author":"Adam","year":"2009","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.thromres.2014.12.026_bb0125","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/j.1538-7836.2012.04858.x","article-title":"Low borderline plasma levels of antithrombin, protein C and protein S are risk factors for venous thromboembolism","volume":"10","author":"Bucciarelli","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"8","key":"10.1016\/j.thromres.2014.12.026_bb0130","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/MBC.0b013e3283650cf9","article-title":"Efficacy of the prothrombin complex concentrate prothromplex in patients requiring urgent reversal of vitamin K antagonists or presenting with uncontrolled bleeding: a retrospective, single center study","volume":"24","author":"Leal-Noval","year":"2013","journal-title":"Blood Coagul Fibrinolysis"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814006951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814006951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T15:15:12Z","timestamp":1598627712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384814006951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0049384814006951"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2014.12.026","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An international, multicenter, prospective study of a prothrombin complex concentrate, Prothromplex Total\u00ae, in anticoagulant reversal","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2014.12.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}